Sherbrooke Park Advisers LLC Veracyte, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 9,493 shares of VCYT stock, worth $285,929. This represents 0.12% of its overall portfolio holdings.
Number of Shares
9,493
Previous 8,875
6.96%
Holding current value
$285,929
Previous $302 Million
24.43%
% of portfolio
0.12%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
76.3MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$247 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$235 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$199 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$127 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$92.8 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.16B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...